Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 64Head & Neck 28Thoracic 19Other solid neoplasm 11Tumor-Agnostic 5Gynecologic 3CNS 3Breast 3Dermatologic 2Sarcoma 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Genitourinary 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

Cyclophosphamide 174Rituximab 146venetoclax 82Specimen Handling 81fludarabine 80Vincristine 69obinutuzumab 68Prednisone 66Doxorubicin 66Biopsy 63Magnetic Resonance Spectroscopy 62Lenalidomide 54zanubrutinib 52Dexamethasone 48Cytarabine 44Methotrexate 43blinatumomab 41Immunotherapy, Adoptive 40acalabrutinib 37Bendamustine Hydrochloride 37fludarabine phosphate 32Etoposide 32ibrutinib 30polatuzumab vedotin 27glofitamab 27pirtobrutinib 25orelabrutinib 25Gemcitabine 24Injections 21Mercaptopurine 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Cetuximab × Lymphoid × Clear all
NCT06447987 2025-12-17

Humanized CD19-Specific CAR T Cells for the Treatment of Patients With Positive Relapsed or Refractory CD19 Positive B-Cell Acute Lymphoblastic Leukemia

City of Hope Medical Center

Phase 1 Recruiting
24 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡